Matches in Wikidata for { <http://www.wikidata.org/entity/Q80558321> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q80558321 description "article scientifique publié en 2007" @default.
- Q80558321 description "artículu científicu espublizáu en xunetu de 2007" @default.
- Q80558321 description "scientific article published on 02 July 2007" @default.
- Q80558321 description "wetenschappelijk artikel" @default.
- Q80558321 description "наукова стаття, опублікована в липні 2007" @default.
- Q80558321 description "գիտական հոդված հրատարակված 2007 թվականի հուլիսի 2-ին" @default.
- Q80558321 name "Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy" @default.
- Q80558321 name "Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy" @default.
- Q80558321 type Item @default.
- Q80558321 label "Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy" @default.
- Q80558321 label "Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy" @default.
- Q80558321 prefLabel "Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy" @default.
- Q80558321 prefLabel "Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy" @default.
- Q80558321 P1433 Q80558321-604FC6E6-F2AD-4868-9391-D948359091E1 @default.
- Q80558321 P1476 Q80558321-A4C4BDD9-DC6A-4B61-BDBC-0E4BB9297B80 @default.
- Q80558321 P2093 Q80558321-0C562428-ABB1-457F-8273-317570FF28F8 @default.
- Q80558321 P2093 Q80558321-107D2A4A-27F3-4A6C-9057-2B7524DA4BBC @default.
- Q80558321 P2093 Q80558321-13524159-73C0-4505-9208-A22D999BA992 @default.
- Q80558321 P2093 Q80558321-45E27BE5-609F-46DB-BA5E-6BAF2532C33E @default.
- Q80558321 P2093 Q80558321-510D7B83-9419-46C6-A971-16F79DD870E8 @default.
- Q80558321 P2093 Q80558321-56716797-1794-4913-8D1C-1BDFF410D5EA @default.
- Q80558321 P2093 Q80558321-6921BFE6-0FA3-4A3B-9CBE-900C3FB5DE24 @default.
- Q80558321 P2093 Q80558321-7E3325D3-B125-4E02-B189-7B8427E02924 @default.
- Q80558321 P2093 Q80558321-8C15261F-3786-487B-8D4F-0508A2F6E875 @default.
- Q80558321 P2093 Q80558321-A9E75C01-527A-48DB-A25D-C2175EED2850 @default.
- Q80558321 P2093 Q80558321-B6F94A92-6D38-453C-8130-670331446FA3 @default.
- Q80558321 P2093 Q80558321-D5B2508C-7519-4D62-BB91-B262E9384884 @default.
- Q80558321 P304 Q80558321-2961FBC1-700A-47CF-91F8-BC41B65D1DD0 @default.
- Q80558321 P31 Q80558321-BB892BAF-21E7-4325-8198-E5DBDB662B8D @default.
- Q80558321 P356 Q80558321-EDA1C8D8-38F4-4B28-A318-FB0351947733 @default.
- Q80558321 P433 Q80558321-85EF16D0-A328-4553-83F5-ED0C7D4E3028 @default.
- Q80558321 P478 Q80558321-4B4903D7-8EFA-4C0B-88C1-AE24C2D83425 @default.
- Q80558321 P50 Q80558321-1BBE7E09-092E-4BD2-91DC-4A4071EC4A82 @default.
- Q80558321 P577 Q80558321-3D839530-F8F5-428F-9BBA-D2253FAA738B @default.
- Q80558321 P698 Q80558321-55AD0E06-C697-4D9D-8130-259D4F50F65D @default.
- Q80558321 P921 Q80558321-572CEC30-2C5A-4374-A717-CC1D065A14B3 @default.
- Q80558321 P921 Q80558321-5AA1CB22-19ED-474C-8546-3AFF296BAD68 @default.
- Q80558321 P921 Q80558321-D834BA43-592D-4554-BF11-9C7D684E29A5 @default.
- Q80558321 P356 JCO.2006.09.7535 @default.
- Q80558321 P698 17606972 @default.
- Q80558321 P1433 Q400292 @default.
- Q80558321 P1476 "Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy" @default.
- Q80558321 P2093 "Craig Bunnell" @default.
- Q80558321 P2093 "David Lebwohl" @default.
- Q80558321 P2093 "Francesco Cognetti" @default.
- Q80558321 P2093 "Henri Roché" @default.
- Q80558321 P2093 "Hervé Curé" @default.
- Q80558321 P2093 "Jean-Pierre Delord" @default.
- Q80558321 P2093 "Joseph Sparano" @default.
- Q80558321 P2093 "Louis Mauriac" @default.
- Q80558321 P2093 "Louise Yelle" @default.
- Q80558321 P2093 "Pierre Kerbrat" @default.
- Q80558321 P2093 "Rana Ezzeddine" @default.
- Q80558321 P2093 "Ronald Peck" @default.
- Q80558321 P304 "3415-3420" @default.
- Q80558321 P31 Q13442814 @default.
- Q80558321 P356 "10.1200/JCO.2006.09.7535" @default.
- Q80558321 P433 "23" @default.
- Q80558321 P478 "25" @default.
- Q80558321 P50 Q40149511 @default.
- Q80558321 P577 "2007-07-02T00:00:00Z" @default.
- Q80558321 P698 "17606972" @default.
- Q80558321 P921 Q11711607 @default.
- Q80558321 P921 Q12859063 @default.
- Q80558321 P921 Q42824440 @default.